Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(48)
•••
Comment by langostaon Jun 03, 2018 8:36am
137 Views
Post# 28116792

RE:RE:RE:well if

RE:RE:RE:well if
Thor6570 wrote:
 Articles in the paper on radio etc happen all the time announcing potential breakthrough 's that will continue to be researched, the news articles also odten include grants from gov's , business , charities etc. As well businesses all over Canada are given grants interest free loans and yet we have no media coverage no grants notta nothing burger. Anyone here have a theory?


1) Why is it only in the 30c range ?

2) It's too good to be true.

3) Suppression by big Pharma?

4) Unsettled management ?

5) Deliberately keeping a low profile ?

6) It's on the vulture xchange.

7) Comments ,
2015) This thing is going to the moon: Didn't happen
2016)  We're headin on up, way up:     Didn't happen
2017)  This thing is going to explode.   Didn't happen
2018)  This will be our year: Waiting.
2019)  OK. Maybe this year. :-))

In other words: I have no idea.  
   
     
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities